A Comprehensive Diagnostic Offering Workflow Increases the Rate of Actionable Results of the 23- and 35-Gene Expression Profile Tests for Use As Ancillary Diagnostic Tools for Difficult-to-Diagnose Melanocytic Lesions. J of Skin 2021, 5 (6), s79. https://doi.org/10.25251/skin.5.supp.79.